Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genes - PubMed (original) (raw)
doi: 10.1038/sj.ejhg.5200698.
A Zimprich, P J Lockhart, M Farrer, A Singleton, B Holtom, S Lincoln, A Hofer, L Hill, B Müller-Myhsok, Z K Wszolek, J Hardy, T Gasser
Affiliations
- PMID: 11571553
- DOI: 10.1038/sj.ejhg.5200698
Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genes
A B West et al. Eur J Hum Genet. 2001 Sep.
Abstract
Parkinson's disease (PD) is a common neurodegenerative disorder with clinical features of bradykinesia, rigidity, resting tremor and postural instability resulting from the deficiency of dopamine in the nigrostriatal system. Previously we mapped a susceptibility gene for an autosomal dominant form of PD to a 10.6 cM region of chromosome 2p (PARK3; OMIM 602404). A common haplotype shared by two North American kindreds (Families B and C) genealogically traced to Southern Denmark and Northern Germany suggested a founder effect. Here we report progress in the refinement of the PARK3 locus and sequence analysis of candidate genes within the region. Members of families B and C were genotyped using polymorphic markers, reducing the minimum common haplotype to eight markers spanning a physical distance of 2.5 Mb. Analysis of 14 genes within the region did not reveal any potentially pathogenic mutations segregating with the disease, implying that none of these genes are likely candidates for PARK3.
Similar articles
- The human sideroflexin 5 (SFXN5) gene: sequence, expression analysis and exclusion as a candidate for PARK3.
Lockhart PJ, Holtom B, Lincoln S, Hussey J, Zimprich A, Gasser T, Wszolek ZK, Hardy J, Farrer MJ. Lockhart PJ, et al. Gene. 2002 Feb 20;285(1-2):229-37. doi: 10.1016/s0378-1119(02)00402-x. Gene. 2002. PMID: 12039050 - A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study.
Karamohamed S, DeStefano AL, Wilk JB, Shoemaker CM, Golbe LI, Mark MH, Lazzarini AM, Suchowersky O, Labelle N, Guttman M, Currie LJ, Wooten GF, Stacy M, Saint-Hilaire M, Feldman RG, Sullivan KM, Xu G, Watts R, Growdon J, Lew M, Waters C, Vieregge P, Pramstaller PP, Klein C, Racette BA, Perlmutter JS, Parsian A, Singer C, Montgomery E, Baker K, Gusella JF, Fink SJ, Myers RH, Herbert A; GenePD study. Karamohamed S, et al. Neurology. 2003 Dec 9;61(11):1557-61. doi: 10.1212/01.wnl.0000095966.99430.f4. Neurology. 2003. PMID: 14663042 - Search for the PARK3 founder haplotype in a large cohort of patients with Parkinson's disease from northern Germany.
Klein C, Vieregge P, Hagenah J, Sieberer M, Doyle E, Jacobs H, Gasser T, Breakefield XO, Risch NJ, Ozelius LJ. Klein C, et al. Ann Hum Genet. 1999 Jul;63(Pt 4):285-91. doi: 10.1046/j.1469-1809.1999.6340285.x. Ann Hum Genet. 1999. PMID: 10738540 - A physical and transcript map based upon refinement of the critical interval for PPH1, a gene for familial primary pulmonary hypertension. The International PPH Consortium.
Machado RD, Pauciulo MW, Fretwell N, Veal C, Thomson JR, Vilariño Güell C, Aldred M, Brannon CA, Trembath RC, Nichols WC. Machado RD, et al. Genomics. 2000 Sep 1;68(2):220-8. doi: 10.1006/geno.2000.6291. Genomics. 2000. PMID: 10964520 - Genes causing congenital hydrocephalus: Their chromosomal characteristics of telomere proximity and DNA compositions.
McKnight I, Hart C, Park IH, Shim JW. McKnight I, et al. Exp Neurol. 2021 Jan;335:113523. doi: 10.1016/j.expneurol.2020.113523. Epub 2020 Nov 4. Exp Neurol. 2021. PMID: 33157092 Free PMC article. Review.
Cited by
- PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study.
DeStefano AL, Lew MF, Golbe LI, Mark MH, Lazzarini AM, Guttman M, Montgomery E, Waters CH, Singer C, Watts RL, Currie LJ, Wooten GF, Maher NE, Wilk JB, Sullivan KM, Slater KM, Saint-Hilaire MH, Feldman RG, Suchowersky O, Lafontaine AL, Labelle N, Growdon JH, Vieregge P, Pramstaller PP, Klein C, Hubble JP, Reider CR, Stacy M, MacDonald ME, Gusella JF, Myers RH. DeStefano AL, et al. Am J Hum Genet. 2002 May;70(5):1089-95. doi: 10.1086/339814. Epub 2002 Mar 27. Am J Hum Genet. 2002. PMID: 11920285 Free PMC article. - Transcriptional regulation of the beta-synuclein 5'-promoter metal response element by metal transcription factor-1.
McHugh PC, Wright JA, Brown DR. McHugh PC, et al. PLoS One. 2011 Feb 28;6(2):e17354. doi: 10.1371/journal.pone.0017354. PLoS One. 2011. PMID: 21386983 Free PMC article. - The sepiapterin reductase gene region reveals association in the PARK3 locus: analysis of familial and sporadic Parkinson's disease in European populations.
Sharma M, Mueller JC, Zimprich A, Lichtner P, Hofer A, Leitner P, Maass S, Berg D, Dürr A, Bonifati V, De Michele G, Oostra B, Brice A, Wood NW, Muller-Myhsok B, Gasser T; European Consortium on Genetic Susceptibility in Parkinson's Disease (GSPD). Sharma M, et al. J Med Genet. 2006 Jul;43(7):557-62. doi: 10.1136/jmg.2005.039149. Epub 2006 Jan 27. J Med Genet. 2006. PMID: 16443856 Free PMC article. - Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson's Disease.
Oczkowska A, Kozubski W, Lianeri M, Dorszewska J. Oczkowska A, et al. Curr Genomics. 2013 Dec;14(8):502-17. doi: 10.2174/1389202914666131210205839. Curr Genomics. 2013. PMID: 24532983 Free PMC article. - Genetics of parkinsonism.
Lewthwaite AJ, Nicholl DJ. Lewthwaite AJ, et al. Curr Neurol Neurosci Rep. 2005 Sep;5(5):397-404. doi: 10.1007/s11910-005-0064-6. Curr Neurol Neurosci Rep. 2005. PMID: 16131423 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous